OAR 416-340-0010
Definitions


(1)

Controlled medication: DEA-controlled substances including medications that come under the jurisdiction of the Federal Controlled Substances Act (e.g. narcotics, amphetamines, and certain pain and sleeping medications). These medications have a high risk for abuse or dependence.

(2)

Informed consent: The agreement by a patient (over age 14 for mental health treatment, and over age 15 for medical treatment) to treatment, examination, or procedure after the patient receives facts regarding the nature, consequences, and risks of the proposed treatment, examination or procedure. Informed consent requires that the person giving the consent understands the facts, implications, and potential consequences of an action. Written documentation of consent by an offender or his/her guardian is required for invasive procedures in which there is some risk.

(3)

Medication Administration Record (MAR): The written record used to document the administration of all medication to offenders.

(4)

Pro re nata (PRN): Administered as needed.

(5)

Psychotropic Medication: Medication prescribed to alter brain function for purposes of treating problems with thought processes, mood, or behavior. Psychotropic medications include stimulants, antipsychotics, mood stabilizers, anxiolytics, and sedatives.

(6)

Substitute care: Residential placements in the community that provide 24-hour-a-day care and supervision, excluding a relative’s home. Such placements include, but are not limited to:

(a)

Foster care; and

(b)

Proctor care; and

(c)

Contracted residential treatment providers.
Last Updated

Jun. 8, 2021

Rule 416-340-0010’s source at or​.us